School-age outcomes following a randomized controlled trial of magnesium sulfate for neuroprotection of preterm infants
- PMID: 24837863
- DOI: 10.1016/j.jpeds.2014.04.007
School-age outcomes following a randomized controlled trial of magnesium sulfate for neuroprotection of preterm infants
Abstract
In a French randomized trial, children at school-age demonstrated no evidence of harm from fetal exposure to MgSO4 before very preterm birth. Motor dysfunction/death, qualitative behavioral disorders, cognitive difficulties, school grade repetition, and education services were decreased in the children exposed to MgSO4, although the differences were not significant.
Trial registration: ClinicalTrials.gov NCT00120588.
Copyright © 2014 Elsevier Inc. All rights reserved.
Publication types
MeSH terms
Substances
Associated data
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
